“The available data suggest waning immunity in some populations who are fully vaccinated.
The availability of these authorized boosters is important for continued protection against COVID-19 disease.”
The Centers for Disease Control and Prevention thenapproved Pfizer’s booster shotfor those Americans.
The committee isscheduled to meet Thursdayto discuss Moderna’s andJohnson & Johnson’s booster data, according to CNBC.
TheCOVID-19 vaccines are highly effectiveat preventing hospitalizationand deaths.
Over57% of the US population is fully vaccinatedagainst COVID-19, according to the CDC.
